Founder/General Partner at Civilization Ventures. Shahram's investments include Rewrite (acq. by Intellia), Foresight Diagnostics, Omada Health, Tacit Therapeutics, Replace Therapeutics, Lemonaid Health (acq. by 23andme), Singular Bio (acq. by Invitae), Rocket Pharma (Nasdaq), Billion-to-One, Evonetix, CatalogDNA, Palamedrix (acq. by SomaLogic), and other deep tech leaders.
Location
San Francisco, California
Notable investments
No items found.
Check size range(s)
$0 - $100K
$100K - $500K
$500K - $1M
$1M - $3M
$3M - $10M
Rounds their fund invests in
Seed
Series A
Rounds their fund leads
No items found.
Sectors their fund invests in
Biotech
Health
Geographies their fund invests in
USA
Browse through a massive startup database
Browse Harmonic, our favorite resource for parsing through the world's startup data.
Partner
Learn more about Harmonic
No items found.
No colleagues here yet.
Funds they're a part of
Civilization Ventures
About the Fund
Focused on cutting edge innovations in exponential health tech and biology
View Profile
Their Colleagues
No colleagues here yet.
Sheets Their fund(s) are in
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP
Related Investors
Round-focused Sheets
Geography-focused Sheets
Sector-focused Sheets
